Safe, effective, and accessible care is the promise of AI in healthcare—but without trust, governance, and accountability, that promise fails at scale.
Healthcare has long relied on a covenant of trust between clinicians and patients. As artificial intelligence enters clinical care, that...
Artificial intelligence will reshape healthcare only if society agrees on how it should be governed. A new social contract must...
Like financial markets before modern regulation, healthcare AI risks scaling failures without structured oversight. The HART framework proposes governance ...
Healthcare must treat algorithms with the same vigilance applied to drugs and medical devices. Continuous monitoring, transparent evaluation, and accountable...
Voluntary guidelines and ethical principles alone cannot ensure safe adoption of healthcare AI. Durable progress requires enforceable governance structures that...
Healthcare AI depends on vast datasets drawn from patients and clinical systems. Determining who owns, controls, and benefits from this...
Medication shortages expose structural weaknesses in healthcare supply chains and regulatory oversight. When essential drugs disappear ...
The economics of pharmaceuticals influence who receives care and who does not. Rising drug prices and opaque market structures raise...
When national regulatory frameworks weaken or lag behind technology, healthcare organizations cannot wait. Institutions must develop their own governance ...
As digital health systems expand, patients increasingly expect transparency and agency over their medical data. Empowering patients with access...
AI can augment clinical decision-making, but it cannot replace professional judgment. Maintaining human oversight ensures that algorithms remain tools...
Successful adoption of artificial intelligence in healthcare requires leadership that bridges clinical practice, technology, ethics, and governance. Determining who holds...